57% Reduction in Total Cholesterol from Nyrada’s NYX-PCSK9i In Vivo Study Jan 25, 2021 ASX News Nyrada Inc (ASX:NYR) Send Share Share
Nyrada’s PCSK9 Inhibitor Evaluated In Novel Model Of Atherosclerosis Jul 20, 2022 | ASX News, Nyrada Inc (ASX:NYR)
Harvest Technology Group releases the Infinity Nodestream Downloadable Decoder Application Jan 29, 2021 | ASX News, Harvest Technology Group (ASX:HTG)
Incannex Receives Ethics Approval to Commence Phase 1 Clinical Trial of Multi-Use Anti-Inflammatory Drug IHL-675A Jul 21, 2022 | ASX News, Incannex Healthcare (ASX:IHL)
Nyrada Inc Brain Injury Program Update and Pathway to Phase I Jan 4, 2022 | ASX News, Nyrada Inc (ASX:NYR)